IBU tablet

Šalis: Jungtinės Valstijos

kalba: anglų

Šaltinis: NLM (National Library of Medicine)

Veiklioji medžiaga:

IBUPROFEN (UNII: WK2XYI10QM) (IBUPROFEN - UNII:WK2XYI10QM)

Prieinama:

Direct _Rx

Vartojimo būdas:

ORAL

Recepto tipas:

PRESCRIPTION DRUG

Terapinės indikacijos:

Carefully consider the potential benefits and risks of Ibuprofentablets and other treatment options before deciding to use Ibuprofen.Use the lowest effective dose for the shortest duration consistent withindividual patient treatment goals (see WARNINGS). IBU tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. IBU tablets are indicated for relief of mild to moderate pain. IBU tablets are also indicated for the treatment of primary dysmenorrhea. Controlled clinical trials to establish the safety and effectiveness of IBU tablets in children have not been conducted. IBU tablets are contraindicated in patients with known hypersensitivityto ibuprofen. IBU tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin orother NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients (see WARNINGS, Anaphylactoid Reactions, and PRECAUTIONS, Preexisting Asthma

Produkto santrauka:

IBU tablets are available in the following strengths, colors and sizes: 400 mg (white, oval, debossed 4I) Bottles of 90 Bottles of 100 Bottles of 500 (PACKAGE NOT CHILD-RESISTANT) 600 mg (white, caplet, debossed 6I) Bottles of 30 Bottles of 50 Bottles of 90 Bottles of 100 Bottles of 500 (PACKAGE NOT CHILD-RESISTANT) 800 mg (white, caplet, debossed 8I) Bottles of 30 Bottles of 50 Bottles of 60 Bottles of 90 Bottles of 100 Bottles of 500 (PACKAGE NOT CHILD-RESISTANT) Store at room temperature. Avoid excessive heat 40°C (104°F). Manufactured by: Dr. Reddy’s Laboratories Louisiana, LLC Shreveport, LA 71106 USA Revised: April 2019

Autorizacija statusas:

Abbreviated New Drug Application

Pakuotės lapelis

IBU- IBU TABLET
Direct _Rx
----------
Medication Guide forNon-Steroidal Anti-Inflammatory Drugs (NSAIDs)
What it the most important information I should know about medicines
called Non-Steroidal Anti-
Inflammatory Drugs (NSAIDs)?
NSAIDs can cause serious side effects, including:
• Increased risk of a heart attack or stroke that can lead to death.
This risk may happen early in treatment
and may increase:
° with increasing doses of NSAIDs
° with longer use of NSAIDs
Do not take NSAIDs right before or after a heart surgery called a
"coronary artery bypass graft (CABG)."
Avoid taking NSAIDs after a recent heart attack, unless your
healthcare provider tells you to. You may
have an increased risk of another heart attack if you take NSAIDs
after a recent heart attack.
•Increased risk of bleeding, ulcers, and tears (perforation) of the
esophagus (tube leading from the mouth
to the stomach), stomach and intestines:
° anytime during use
° without warning symptoms
° that may cause death
The risk of getting an ulcer or bleeding increases with:
° past history of stomach ulcers, or stomach or intestinal bleeding
with use of NSAIDs
° taking medicines called "corticosteroids", "anticoagulants",
"SSRIs", or "SNRIs"
° increasing use of NSAIDs
° longer use of NSAIDs
° smoking
° drinking alcohol
° older age
° poor health
° advanced liver disease
° bleeding problems
NSAIDs should only be used:
° exactly as prescribed
° at the lowest dose possible for your treatment
° for the shortest time needed
What are NSAIDs?
NSAIDs are used to treat pain and redness, swelling, and heat
(inflammation) from medical conditions
such as different types of arthritis, menstrual cramps, and other
types of short-term pain.
Who should not NSAIDs?
Do not take NSAIDs:
• if you had an asthma attack, hives, or other allergic reaction
with aspirin or any other NSAIDs
• right before or after heart bypass surgery
Before taking NSAIDs, tell your healthcare provider about all your
medical conditions, including if you:
• have liver or kid

Prekės savybės

IBU- IBU TABLET
DIRECT _RX
----------
IBU
BOXED WARNING
Cardiovascular Thrombotic Events
Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased risk
of serious
cardiovascular thrombotic events, including myocardial infarction and
stroke, which can be fatal.
This risk may occur early in treatment and may increase with duration
of use. (See WARNINGS
and PRECAUTIONS).
IBU tablets are contraindicated in the setting of coronary artery
bypass graft (CABG) surgery
(See CONTRAINDICATIONS and WARNINGS).
Gastrointestinal Risk
NSAIDS cause an increased risk of serious gastrointestinaladverse
events including bleeding,
ulceration, and perforationof the stomach or intestines, which can be
fatal. These eventscan occur
at any time during use and without warning symptoms.Elderly patients
are at greater risk for
serious gastrointestinalevents. (See WARNINGS).
IBU tablets contain the active ingredient ibuprofen, which is (±) -2
- (p - isobutylphenyl) propionic acid.
Ibuprofen is a white powde rwith a melting point of 74-77° C and is
very slightly soluble in water(<1
mg/mL) and readily soluble in organic solvents such as ethanol and
acetone. The structural formula is
represented below:
[strucuture]
IBU, a nonsteroidal anti-inflammatory drug (NSAID), is availablein 400
mg, 600 mg, and 800 mg tablets
for oral administration.Inactive ingredients: carnauba wax, colloidal
silicon dioxide,croscarmellose
sodium, hypromellose, magnesium stearate, microcrystallinecellulose,
polydextrose, polyethylene
glycol, polysorbate,titanium dioxide.
IBU tablets contain ibuprofen which possesses analgesic andantipyretic
activities. Its mode of action,
like that of other NSAIDs, isnot completely understood, but may be
related to prostaglandin
synthetaseinhibition.
In clinical studies in patients with rheumatoid arthritis
andosteoarthritis, Ibuprofen tablets have been
shown to be comparableto aspirin in controlling pain and inflammation
and to be associatedwith a
statistically significant reduction in the milder gastrointestinalside
effects (s